Carbohydrates and drug design

ACS Symposium Series

Volumn 1102, Issue , 2012, Pages 3-22

  Klyosov, Anatole A ^a  

^a Galectin Therapeutics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DESIGN; DRUG DELIVERY; DRUG INTERACTIONS;

BIOLOGICAL MOLECULE; CARBOHYDRATE CHEMISTRY; COMPUTATIONAL STUDIES; DRUG CANDIDATES; GLYCOSYLATION REACTIONS; PRESCRIPTION DRUGS; STRUCTURAL ELEMENTS; THERAPEUTIC VALUES;

CARBOHYDRATES;

EID: 84886584426     PISSN: 00976156     EISSN: 19475918     Source Type: Book Series    
DOI: 10.1021/bk-2012-1102.ch001     Document Type: Conference Paper

References (6)

1. Sellick, I. Streamlining conjugate vaccine production. Genet. Eng. News 2004, 24 (16), 48-52.
2. Ellis, R. Therapeutic vaccines gain growing interest. Genet. Eng. News 2004, 24 (21), 25-28.
3. Filmore, D. HIV vaccine testing. Mod. Drug Discovery 2004 (August), 11.
4. Lesney, M. S. Vaccine futures. Mod. Drug Discovery 2002 (March), 35-40.
5. Yokoyama, K.; Biswas, S. K.; Miyaji, M.; Nishimura, K. Identification and phylogenetic relationship of the most common pathogenic Candida species inferred from mitochondrial cytochrome b gene sequences. J. Clin. Microbiol. 2000, 38, 4503-4510.
6. Rodrigues, A. G.; Pina-Vaz, C.; Costa-de-Oliveira, S.; Tavares, C. Expression of plasma coagulase among pathogenic Candida species. J. Clin. Microbiol. 2003, 41, 5792-5793.